Team AMAL

Leadership Team

AMAL Therapeutics is led by a dedicated team with a strong background in molecular and cellular biotechnology R&D gained from working within start-ups, at renowned Academic Institutes, as well as large pharma companies.

Dr Laetitia Devy-Dimanche

Dr Laetitia Devy-Dimanche

Chief Executive Officer
Dr Keith Wilson

Dr Keith Wilson

VP CMC & Manufacturing
Dr Elodie Belnoue

Dr Elodie Belnoue

Senior Director - Translational Research
Dr Marie-Laure Santiago-Raber

Dr Marie-Laure Santiago-Raber

Chief Scientific Officer
Aurélie Kowalski

Aurélie Kowalski

Chief of Staff
Dr Hanjing Xie, MD, Associate Prof.

Dr Hanjing Xie, MD, Associate Prof.

Chief Medical Officer

You are now leaving our website

Using this link will let you leave a website of Amal Therapeutics or to a different domain under the control of Amal Therapeutics. In the event that the linked site is not under the control of Amal Therapeutics but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, Amal Therapeutics shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites.

This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Amal Therapeutics of the site.

Target URL:

OK